Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MS6B
|
|||
| Former ID |
DNCL002231
|
|||
| Drug Name |
LOR 253
|
|||
| Indication | Metastatic cancer [ICD-11: 2D50-2E2Z; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Lorus Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01281592) A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.